Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2011-05-31
2011-05-31
Yu, Misook (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S007100
Reexamination Certificate
active
07951528
ABSTRACT:
The invention is directed to a method for detecting colorectal adenoma and/or colorectal carcinoma comprising the steps: a) providing an isolated sample material which has been taken from an individual, b) determining the level of transthyretin in said isolated sample material, and c) comparing the determined level of transthyretin with a reference value. The invention is further directed to a method for discriminating between colorectal adenoma and colorectal carcinoma as well as to a method for monitoring the course of colorectal adenoma and/or colorectal carcinoma and/or the treatment of colorectal adenoma and/or colorectal carcinoma. Moreover, the invention is directed to a test system and an array for use in these methods. Furthermore, the invention is directed to the use of transthyretin as a biomarker for a detection of colorectal adenoma and/or colorectal carcinoma in an individual.
REFERENCES:
patent: 2001/0023066 (2001-09-01), Kinders et al.
patent: 11-505019 (1999-05-01), None
patent: 2008-509407 (2008-03-01), None
patent: WO96/35955 (1996-11-01), None
patent: WO04/001072 (2003-12-01), None
patent: WO 2004/013609 (2004-02-01), None
patent: WO2006/015616 (2006-02-01), None
patent: WO2006/102526 (2006-09-01), None
Kingsbury et al., May 2, 2008 The Journal of Biological Chemistry, 283, 11887-11896.
Pasche, et al., Best Practice of Research Clinical Gastroenterology, vol. 16, No. 2, pp. 331-345(2002).
Basu, et al., J. Clin. Biochemistry and Nutrition, vol. 10, No. 1, pp. 65-70 (1991).
Gu, et al., Science in China, vol. 34, No. 11, pp. 1312-1318 (Nov. 1991).
Zhen, et al., Proceedings of the American Association for Cancer Research, vol. 45, p. 1303 (Mar. 2004).
Bullen, et al., Med. Ped. Oncol., vol. 3, pp. 289-300 (1977).
Milano, et al., J. Nat. Cancer Inst., vol. 61, No. 3, pp. 687-691 (Sep. 1978).
Hollinshead, et al., Nat. Cancer Inst. Monographs, vol. 49, pp. 187-192(Dec. 1978).
Fujimori, et al., Jap. Journal of Gastroenterological Surgery, vol. 24, No. 9, pp. 2363-2372 (1991).
Yuceyar, et al., Int. Surg., vol. 81, pp. 136-139 (1996).
Roboz, et al., www.aacrmeetingabstracts.org/cgi/content/abstract/2004/1/819 (2004).
Swahn, et al., Complement Activation in Ovarian Cancer, Poster Sessions, Abstract 1187, Oct. 24, 2001.
Official Action dated Oct. 26, 2009; in Japanese Patent Application No. 2007-525256.
Matsui, Rinshoi, vol. 25, No. 10, pp. 1922-1926(1999) and English Translation Thereof.
Decision of Refusal in corresponding Japanese Patent Application No. 2007-525176, dated Dec. 27, 2010 and English Translation Thereof.
David Kerstin
Juhl Hartmut
Duffy Brad
Invidumed GmbH
Lillie Raymond J.
Olstein Elliot M.
Yu Misook
LandOfFree
Use of transthyretin as a biomarker for colorectal adenoma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of transthyretin as a biomarker for colorectal adenoma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of transthyretin as a biomarker for colorectal adenoma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666545